Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.

Author(s): Balague CE, de Ruiz CS, Rey R, de Duffard AM, Nader-Macias ME

Affiliation(s): Laboratorio de Toxicologia Experimental, Universidad Nacional de Rosario, Suipacha 531, 2000 Rosario, Argentina. tonu14@aol.com

Publication date & source: 2004-11-01, FEMS Immunol Med Microbiol., 42(3):313-9.

Publication type:

Interfering Escherichia coli attachment to the urinary tract, using P-fimbriation inhibitors, can prevent pyelonephritis. Clofibric and ethacrynic acids are organic compounds structurally related, but with different pharmacological uses. These agents are potentially active in the urinary tract due to its elimination in an unaltered form by the renal route. This study described a pyelonephritogenic E. coli strain, grown in the presence of sub-inhibitory concentrations of clofibric or ethacrynic acids (0.1 and 1 mM, respectively), which exhibits inhibition of P1 erythrocytes agglutination and a drastic decrease in fimbriation, using electron microscopy and quantitative analyses of superficial proteins (decrease to a 17-25% in comparison with the control). In vivo assays were performed using ascending urinary tract infection in mice. The treatment with therapeutic doses of the drugs, administered 2 days before the bacterial challenge and daily until the end of the experiment (22 days), abolished renal infection after 7-10 days of drug exposure. Within this period clofibric acid did not produce adverse effects on the renal parenchyma. However, ethacrynic acid caused pyelitis and tubular cellular desquamation. These results suggested that clofibric acid might be useful in the short-term prophylaxis of urinary tract infection.